Literature DB >> 33986848

miR-660 promotes liver cancer cell proliferation by targeting PPP2R2A.

Yaozhen Pan1,2, Lei Zhan3, Ling Chen2, Liwen Chen2, Chengyi Sun2.   

Abstract

Liver cancer (LC) is the leading cause for tumor-related death worldwide, and microRNAs (miRs) have been demonstrated to regulate the progression of LC. In the current study, the function of miR-660 in LC cells was investigated, and the results indicated that miR-660 was highly expressed in LC tissues and cells. This increased expression promoted LC cell proliferation and increased the percentage of S phase cells, while miR-660 knockdown inhibited cell proliferation and increased the percentage of G0/G1 phase cells. A Ser/Thr phosphatase protein phosphatase 2 regulatory subunit βα (PPP2R2A) was indicated as the target of miR-660, and miR-660 could inhibit PPP2R2A levels. The luciferase reporter assay suggested that miR-660 directly bound to the 3'-untranslated region of PPP2R2A. Additionally, it was revealed that miR-660 inhibited p21 expression and promoted cyclin D1 expression, confirming that miR-660 regulated LC cell proliferation by regulating cell cycle progression. The double knockdown of miR-660 and PPP2R2A promoted LC cell proliferation, suggesting that miR-660 promoted LC proliferation by targeting PPP2R2A.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  cell proliferation; hepatocellular carcinoma; microRNA-660; protein phosphatase 2 regulatory subunit βα

Year:  2021        PMID: 33986848      PMCID: PMC8112136          DOI: 10.3892/etm.2021.10115

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  27 in total

Review 1.  New roles of cyclin D1.

Authors:  Richard G Pestell
Journal:  Am J Pathol       Date:  2013-07       Impact factor: 4.307

2.  Upregulation of miR-136 in human non-small cell lung cancer cells promotes Erk1/2 activation by targeting PPP2R2A.

Authors:  Sining Shen; Han Yue; Yin Li; Jianjun Qin; Ke Li; Ying Liu; Jiaxiang Wang
Journal:  Tumour Biol       Date:  2014-01

3.  The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitry.

Authors:  Alina Simerzin; Elina Zorde-Khvalevsky; Mila Rivkin; Revital Adar; Jessica Zucman-Rossi; Gabrielle Couchy; Tania Roskams; Olivier Govaere; Moshe Oren; Hilla Giladi; Eithan Galun
Journal:  Hepatology       Date:  2016-07-25       Impact factor: 17.425

4.  MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.

Authors:  YuXiang Fang; Jing-Lun Xue; Qi Shen; Jinzhong Chen; Ling Tian
Journal:  Hepatology       Date:  2012-06       Impact factor: 17.425

5.  MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation.

Authors:  Ulf Andersson Ørom; Finn Cilius Nielsen; Anders H Lund
Journal:  Mol Cell       Date:  2008-05-23       Impact factor: 17.970

6.  MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data.

Authors:  Jun-Ichi Satoh; Yoshihiro Kino; Shumpei Niida
Journal:  Biomark Insights       Date:  2015-04-15

7.  MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma.

Authors:  Fenqiang Xiao; Wu Zhang; Liming Chen; Fei Chen; Haiyang Xie; Chunyang Xing; Xiaobo Yu; Songming Ding; Kangjie Chen; Haijun Guo; Jun Cheng; Shusen Zheng; Lin Zhou
Journal:  J Transl Med       Date:  2013-08-22       Impact factor: 5.531

8.  Simplified production and concentration of lentiviral vectors to achieve high transduction in primary human T cells.

Authors:  Adam P Cribbs; Alan Kennedy; Bernard Gregory; Fionula M Brennan
Journal:  BMC Biotechnol       Date:  2013-11-12       Impact factor: 2.563

9.  Smad4-dependent suppressor pituitary homeobox 2 promotes PPP2R2A-mediated inhibition of Akt pathway in pancreatic cancer.

Authors:  Qi Wang; Juanjuan Li; Wei Wu; Ruizhe Shen; He Jiang; Yuting Qian; Yanping Tang; Tingting Bai; Sheng Wu; Lumin Wei; Yi Zang; Ji Zhang; Lifu Wang
Journal:  Oncotarget       Date:  2016-03-08

10.  Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3.

Authors:  Ling Xu; Weiqi Dai; JingJing Li; Lei He; Fan Wang; Yujing Xia; Kan Chen; Sainan Li; Tong Liu; Jie Lu; Yingqun Zhou; Yugang Wang; Chuanyong Guo
Journal:  Oncotarget       Date:  2016-05-03
View more
  1 in total

1.  miR-600 promotes ovarian cancer cells stemness, proliferation and metastasis via targeting KLF9.

Authors:  Lili Shan; Pingping Song; Yangyang Zhao; Na An; Yanqiu Xia; Yue Qi; Hongyan Zhao; Jing Ge
Journal:  J Ovarian Res       Date:  2022-05-03       Impact factor: 5.506

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.